GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Enhabit Inc (NYSE:EHAB) » Definitions » COGS-to-Revenue

Enhabit (Enhabit) COGS-to-Revenue : 0.51 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Enhabit COGS-to-Revenue?

Enhabit's Cost of Goods Sold for the three months ended in Mar. 2024 was $134 Mil. Its Revenue for the three months ended in Mar. 2024 was $262 Mil.

Enhabit's COGS to Revenue for the three months ended in Mar. 2024 was 0.51.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Enhabit's Gross Margin % for the three months ended in Mar. 2024 was 48.86%.

Enhabit COGS-to-Revenue Historical Data

The historical data trend for Enhabit's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enhabit COGS-to-Revenue Chart

Enhabit Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
0.48 0.50 0.46 0.49 0.51

Enhabit Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.50 0.52 0.52 0.51 0.51

Enhabit COGS-to-Revenue Calculation

Enhabit's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=535.6 / 1046.3
=0.51

Enhabit's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=134.2 / 262.4
=0.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enhabit  (NYSE:EHAB) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Enhabit's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 134.2 / 262.4
=48.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Enhabit COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Enhabit's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Enhabit (Enhabit) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Enhabit Inc (NYSE:EHAB) » Definitions » COGS-to-Revenue
Comparable Companies
AIRS PNTG CYH AVAH AONC PIII TOI BTMD MODV JYNT HCA SAU:4013 SZSE:300015 HKSE:06618 XTER:FRE BKK:BDMS XKLS:5225 BSP:RDOR3 XTER:FME UHS
Traded in Other Exchanges
X34:Germany
Address
6688 N. Central Expressway, Suite 1300, Dallas, TX, USA, 75206
Website
https://www.ehab.com
Enhabit Inc provides home health and hospice services in the United States. It offers care where patients prefer it: in their homes. It operates business in two segments: home health and hospice. Its home health agencies provide a comprehensive range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services.
Executives
Jeffrey Bolton director 1016 CIVIC CENTER DRIVE NW, ROCHESTER MN 55901
Shaw L Edward Jr director AETNA INC, 151 FARMINGTON AVE RC4B, HARTFORD CT 06156
Stuart M Mcguigan director 74 AGAMENTICUS AVENUE, CAPE NEDDICK ME 03902
Barry P. Schochet director 100 EAST RIVERCENTER BLVD, 16TH FLOOR, COVINGTON KY 41011
Dylan C Black officer: General Counsel and Secretary 6688 CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Langham Ronald Leroy Jr officer: EVP Clinical Excel. & Strategy 6688 CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Higdon Leo I Jr director 1700 LINCOLN STREET, 28TH FLOOR, DENVER CO 80203
Gregory S Rush director TEKELEC, 26580 W. AGOURA RD., CALABASAS CA 91302
Tina L. Brown-stevenson director 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Erin Hoeflinger director 511 FALLVIEW COURT, SPRINGBORO OH 45066
Tanya Renee Marion officer: Chief Human Resources Officer 6688 NORTH CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Charles M Elson director 1401 61STG STREET S, STETSON UNIV COLLEGE OF LAW, ST PETERSBURG FL 33707
Barbara Ann Jacobsmeyer director, officer: President and CEO 2122 ACTON PARK WAY, BIRMINGHAM AL 35243
Yvonne M Curl director C/O ENHABIT, INC., 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Maupin John E Jr D D S director 103 POWELL COURT SUITE 200, BRENTWOOD TN 37027